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The genus Coccolithovirus is a recently discovered group of
viruses that infect the globally important marine calcifying
microalga Emiliania huxleyi. Surprisingly, the viral genome
contains a cluster of putative sphingolipid biosynthetic genes
not found in other viral genus. To address the role of these genes
in viral pathogenesis, the ehv050 gene predicted to encode a
serine palmitoyltransferase (SPT), the first and rate-limiting
enzyme of sphingolipid biosynthesis, was expressed and charac-
terized in Saccharomyces cerevisiae. We show that the encoded
protein is indeed a fully functional, endoplasmic reticulum-lo-
calized, single-chain SPT. In eukaryotes SPT is a heterodimer
comprised of long chain base 1 (LCB1) and LCB2 subunits.
Sequence alignment and mutational analysis showed that the
N-terminal domain of the viral protein most closely resembled
the LCB2 subunit and the C-terminal domain most closely
resembled the LCB1 subunit. Regardless of whether the viral
protein was expressed as a single polypeptide or as two inde-
pendent domains, it exhibited an unusual preference for myris-
toyl-CoA rather than palmitoyl-CoA. This preference was
reflected by the increased presence of C16-sphingoid bases in
yeast cells expressing the viral protein. The occurrence of a sin-
gle-chain SPT suggested to us that it might be possible to create
other fusion SPTs with unique properties. Remarkably, when
the two subunits of the yeast SPT were thus expressed, the sin-
gle-chain chimera was functional and displayed a novel sub-
strate preference. This suggests that expression of other multi-
subunit membrane proteins as single-chain chimera could
provide a powerful approach to the characterization of integral
membrane proteins.
Sphingolipids are essential structural components of mem-
branes, are enriched in lipid rafts, and have been implicated as
important second messengers in many signaling processes. In
addition, defects in sphingolipidmetabolismare responsible for
a variety of diseases. The enzyme serine palmitoyltransferase
(SPT)2 catalyzes the rate-limiting step of sphingolipid synthe-
sis. In both prokaryotes and eukaryotes the intact enzyme con-
tains two polypeptide chains, and there is no evidence for post-
translational modification of either chain. The prokaryotic
enzyme is a soluble homodimer containing two symmetric
active sites (1). In eukaryotes there is substantial evidence that
the enzyme is an endoplasmic reticular (ER)-localized het-
erodimer containing a single catalytic site formed at the inter-
face between the subunits (2–4). It has also been shown that in
addition to its ability to catalyze the condensation of serinewith
palmitoyl-CoA, the eukaryotic enzyme can catalyze the con-
densation of serine with other acyl-CoAs (5). However, despite
the importance of this enzyme, little is known about its struc-
tural organization and regulation.
Recently, the sequence of a coccolithoviral genome, EhV-86,
was reported (6). This virus infects the marine algae Emiliania
huxleyi, which plays a significant role in the cycling of carbon in
marine environments and is responsible for large algal blooms
that reflect sunlight and heat and have been proposed to influ-
ence global climate. Viral infection results in attenuation of
these blooms and is believed to be important in biogeochemical
cycling in the ocean as well as global climate control (7, 8).
Remarkably, unlike the sequence of any other virus reported to
date, EhV-86 contains a cluster of genes highly homologous to
those which in other systems, from yeast to mammals, have
been shown to encode enzymes of sphingolipid metabolism.
These genes are coordinately expressed within 2 h of infection,
suggesting that their role is to alter algal sphingolipid metabo-
lism (9). A particularly surprising feature of the gene cluster is
the presence of a single open reading frame (ORF), ehv050,
which encodes what appears to be both subunits of a eukary-
otic-like SPT. However, the sequence is also homologous to
other -oxoamine synthases not involved in sphingolipid bio-
synthesis, leaving open the possibility that this gene might
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encode an SPTwith broad substrate specificity or a new class of
-oxoamine synthases capable of catalyzing multiple conden-
sation reactions, including some not involved in sphingolipid
biosynthesis.
Unfortunately, the inability to experimentally manipulate
the genes of the virus or the host makes it difficult to study the
products of the putative sphingolipid gene cluster in the native
organism. Similarly, proving that ehv050 or any other genes in
the cluster are actually involved in sphingolipid synthesis or
that sphingolipids are important in the viral life cycle is also not
possible. To address these questions we have undertaken the
characterization of the putative sphingolipid genes in Saccha-
romyces cerevisiae. We report that the single-chain SPT-like
EhV-86 enzyme restores SPT activity and viability to yeast
mutants lacking endogenous SPT. We further demonstrate
that, unlike the other characterized SPT enzymes, this virally
encoded enzyme displays a preference for myristoyl-CoA. We
have also expressed both yeast and human SPT as single-chain
fusion proteins and show that they are enzymatically active.
This suggests that other multisubunit membrane-associated
enzymes could be similarly expressed, thus providing a power-
ful tool for the study membrane proteins.
EXPERIMENTAL PROCEDURES
Yeast Strains, Media, and Growth—Yeast cells were grown
according to standard procedures (10). The yeast strains used
have been described previously (11).
SPT Protein Expression—The ehv050 ORF was PCR-ampli-
fied from EhV-86 viral DNA and cloned into the yeast vector
pADH2 under the control of the ADH1 promoter for expres-
sion with an N-terminal 3  HA tag. The N- and C-terminal
domains of ehv050, tagged with 3HA andMyc, respectively,
were cloned under the control of either the Ga110 (vLCB2) or
the Gal1 (vLCB1) promoter. Briefly, a PCR fragment encoding
the N-terminal domain of vSPT (codons 1–472) was generated
using the forward primer, 5-AAGGGCGGCCGCTATGTACC-
CATACGAT, and the reverse primer, 5-TTCCGGATCCATG-
CGTTTTCTTTGACTC, cleaved with NotI and BamH1(sites
underlined), and inserted between the NotI and BglII sites of
pESC-LEU to generate an HA-tagged vLCB2. A PCR fragment
encoding the C-terminal domain of the vSPT (codons 473–870)
was generated using the forward primer, 5-AGACCTCGAGTT-
TCACTCCGATGTT, and the reverse primer, 5-AGGCCAAG-
CTTATGTACACGGCCGTA), cleaved with XhoI and HindIII
(sites underlined), and inserted between the XhoI and HindIII
sites of the pESC-URA to generate an N-terminal Myc-tagged
vLCB1. For construction of GFP-vSPT, a GFP gene flanked
by XbaI sites was inserted into an AvrII site introduced into
the vSPT gene at codon 2. Intracellular localization was
determined by fluorescence microscopy as previously
described (12). The yeast Lcb2-Lcb1p fusion was made by
fusing the yeast LCB1 gene to the C terminus of the yeast
LCB2 gene such that the fusion protein contained all of
Lcb2p followed by all of Lcb1p except for its N-terminal
methionine. The human fusion protein contained all of
hLCB2 followed by hLCB1 lacking the first 48 amino acids
(hLCB2-LCB1). The human protein was expressed in Ly-B
cells as previously described (12).
Long-chain Base Extraction and Analysis—Long chain bases
(LCBs) were extracted, derivatized for detection, and resolved
by high performance liquid chromatography according to pub-
lished procedures (13).
Microsome Preparation, Immunoblotting, and SPT Activ-
ity Assays—Yeast and Ly-B microsomal proteins were pre-
pared, resolved using a 4–12% BisTris NuPAGE gel system
(Invitrogen), and visualized by immunoblotting as previ-
ously described using anti-HA (Roche Applied Science),
anti-Myc (Sigma), anti-human LCB1 (Transduction Labora-
tories), and the previously described yeast anti-LCB1 and
anti-LCB2 antibodies (11). Secondary antibodies were pur-
chased from Bio-Rad. SPT was assayed as described previ-
ously (11, 12). The SPT inhibitor myriocin was purchased
from BIOMOL International L.P.
RESULTS
ehv050 Encodes an Active SPT Enzyme—The EhV-86
genome contains an expressed ORF, ehv050, composed of
two tandemly repeated -oxoamine synthase domains.
Alignments revealed the N- and C-terminal domains to be
most closely related to the Lcb2p and Lcb1p subunits,
respectively, of SPT (Fig. 1). In addition to the overall homol-
ogy, the positions of critical catalytic residues in the two
subunits of SPT are conserved in the two viral domains. The
N-terminal domain of the viral protein contains the lysine
residue present in Lcb2p that forms a Schiff’s base with the
pyridoxal 5-phosphate cofactor, and the C-terminal domain
contains a cysteine in a position analogous to that of the
cysteine residue in Lcb1p that has been proposed to lie
across the subunit interface from the lysine in Lcb2p. This
cysteine is critical for enzymatic activity and when mutated
in human SPTLC1 results in the neurodegenerative disease,
HSAN1 (4, 14, 15). Although the viral protein lacks a region
homologous to the N-terminal extensions of yeast and mam-
malian LCB1s, in which the first of their three membrane
spanning domains is located, this extension is not present in
other -oxoamine synthases and is not required for enzy-
matic activity (12). Taken together, these results suggest that
the ehv050 ORF encodes a novel single-chain SPT (vSPT).
To test this hypothesis, the viral gene was expressed in yeast,
and its ability to reverse the LCB requirement of SPT-deficient
yeastmutantswas determined.As shown in Fig. 2, expression of
vSPT rescued the LCB requirement of a yeast lcb1 mutant.
This rescue was not dependent upon yeast Lcb2p since the
vSPT also rescued an lcb1lcb2 double mutant. In addition,
mutation of the conserved lysine in the Lcb2p-like N-terminal
domain ormutation of the conserved cysteine in the Lcb1p-like
C-terminal domain resulted in loss of function (data not
shown).
Although expression of vSPT complemented yeast mutants
lacking endogenous SPT activity, growth was generally slower
and showed greater temperature dependence. In particular,
vSPT did not support growth at 37 °C (Fig. 2). In vitro SPT
activity measurements revealed that microsomes prepared
from vSPT-rescued cells contained 1⁄10 as much activity as
microsomes prepared fromwild type yeast (Table 1). Yeast lcb1
and lcb2 mutants with reduced SPT activity are temperature-
Single-chain Serine Palmitoyltransferases
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sensitive for growth (16). Similarly, mutants lacking Tsc3p,
which is required for optimal SPT activity in yeast, are also
temperature-sensitive (11). Thus, the inability of vSPT-rescued
cells to grow at 37 °C is consistent with the requirement for
higher SPT activity at elevated growth temperatures. The activ-
ity of vSPT was not further decreased in microsomes prepared
from vSPT-rescued cells lacking Tsc3p, indicating that the
vSPT protein is not activated by Tsc3p.
vSPT Condenses Serine with Myristoyl-CoA More Effi-
ciently than with Palmitoyl-CoA—Although the data pre-
sented above are consistent with the interpretation that fail-
ure of the vSPT-rescued mutants to grow at a higher
temperature is due to reduced LCB synthesis, they do not
exclude the possibility that the LCBs generated by the vSPT
are different from wild type yeast. Analysis of LCBs in the
vSPT-rescued yeast revealed that there was significantly less
C20-phytosphingosine (C20-PHS) and more C16-dihy-
FIGURE 1. Ehv050 encodes an 870-amino acid protein composed of tandemly repeated -oxoamine synthase domains. A is an alignment of residues
42–461 of the viral SPT (CLV) with human (HS),Arabidopsis (At2a andAt2b), and yeast (SC) LCB2. The conserved pyridoxal phosphate binding lysine is indicated
with an asterisk (*), and the potential glycosylation sites are indicated by theƒ. B is an alignment of residues 528–804 of the vSPTwith human (HS),Arabidopsis
(At1), and yeast (SC) LCB1. The cysteine residue in the glycinemotif that lies across the subunit interface from the pyridoxal phosphate binding lysine ismarked
with an asterisk (*), and the potential glycosylation sites are indicated by theƒ.
FIGURE 2. vSPT rescues yeastmutants lacking endogenous SPT. vSPTwas
expressed in lcb1 or lcb1tsc3mutant yeast. Wild type yeast and the indi-
catedmutants were spotted onto YPD plates with or without 15M PHS and
incubated at the indicated temperatures.
Single-chain Serine Palmitoyltransferases
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drosphingosine (C16-DHS) and C16-PHS than in wild type
cells (Fig. 3). The high levels of C16-LCBs are especially
striking in light of the fact that the endogenous concentra-
tion of myristate is much lower than the concentration of
palmitate, suggesting that the vSPT has a relative preference
for C14-CoA. Indeed, when cells were grown on myristate,
the relative abundance of C16-LCBs in the vSPT-rescued
cells was even greater (Fig. 3). To more carefully assess the
substrate preference of the vSPT, its ability to catalyze the
condensation of serine with different acyl-CoAs was deter-
mined (Table 1). As predicted by the in vivo LCB profiles,
C14-CoA was the preferred in vitro substrate. Thus, the
vSPT is distinctly different from its yeast counterpart in sub-
strate preference.
In addition to its homology with the subunits of SPT, there is
significant homology between the viral protein and othermem-
bers of the-oxoamine synthase family. The greatest homology
was with 5-aminolevulinate synthase, encoded by the yeast
HEM1 gene and which catalyzes the committed step of heme
biosynthesis, the condensation of succinyl-CoA with glycine.
However, vSPT did not complement a hem1 mutant (Fig. 4A).
Moreover, vSPT was sensitive to myriocin, a sphingosine ana-
logue that is a specific and potent inhibitor of yeast and mam-
malian SPT (17) (Fig. 4B). Thus, although its substrate specific-
ity is somewhat different from previously characterized SPTs,
the viral enzyme is a bona fide SPT that does not appear to have
additional activities.
Structural Plasticity of the vSPT Enzyme—Despite the fact
that the two -oxoamine synthase domains of the ehv050 gene
are contained in a single ORF, it is possible that the protein is
processed by proteolytic cleavage between the two domains
into two polypeptides which then assemble into an active head-
to-tail heterodimer, the structure of all previously character-
ized eukaryotic SPTs. To address this possibility, extracts pre-
pared from yeast cells expressing a functional N-terminally
HA-tagged vSPT were analyzed by immunoblotting. A mem-
brane-associated protein of 96 kDa, the predicted molecular
mass for the full-length protein, was
easily detected; there was no evi-
dence for the presence of a shorter
protein that would have resulted
from cleavage between the putative
Lcb2p and Lcb1p domains (Fig. 5A).
Interestingly however, the full-
length protein was resolved into
multiple molecular species, which
were converted to a single molecu-
lar weight component upon treat-
ment with endoglycosidase H. This
is consistent with the fact that the
viral protein contains several poten-
tialN-linked glycosylation sites (Fig.
1) and suggested that the protein
resides in the ER. The ER localiza-
tion was confirmed by direct visual-
ization of a GFP-vSPT chimera that
showed a pattern of fluorescence
typical of ER proteins, including the
yeast GFP-Lcb1p (Fig. 5B).
Active SPT could also be recon-
stituted by separately expressing the
N- and C-terminal domains of the
vSPT; coexpression of the two
domains restored sufficient activity
to rescue the yeast SPT-deficient
mutants (Fig. 6C). In addition, the
reassembled subunits yielded an
enzyme with the same preference
for myristoyl-CoA as the full-length
FIGURE 3. vSPT-rescued mutants accumulate C16-LCBs.Wild type and the vSPT-rescued lcb1 yeast were
grown in YPD, YPD 0.1 mMmyristate, or YPD 1.0 mMmyristate for several generations before LCB extrac-
tionandanalysis asdescribedunder “Experimental Procedures.” Thepeaks corresponding to the6-aminoquin-
olyl-N-hydroxysuccinimidyl carbamate-derivatized C16-PHS, C16-DHS, C18-PHS, C18-DHS, and the C17-DHS
internal standard along with their retention times are indicated. LU, luminescence units.
TABLE 1
vSPT prefers C14-CoA as substrate
Microsomes were prepared from vSPT-expressing lcb1 and wild type yeast cells,
and SPT activities were assayed using the indicated acyl-CoA substrates. ND, not
determined.
Acyl-CoA chain length SPT ActivityViral SPT Yeast SPT
pmol/mg/min
C4 0.10 ND
C8 0.18 ND
C10 0.57 ND
C12 1.10 37.25
C14 11.00 91.43
C16 7.73 129.32
C18 2.82 62.42
C16:1 1.39 ND
C18:1 5.25 ND
C18:2 1.31 ND
Single-chain Serine Palmitoyltransferases
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protein (Fig. 6D). Thus, the separated domains can reassemble
and fold into an active SPT enzyme with similar properties to
the fusion protein. The data shown in Fig. 6A also suggest that it
is the Lcb2p-like domain that is glycosylated since only this
domain exhibited endoglycosidase H-sensitive heterogeneity.
However, because mutation of the two potential glycosylation
sites in the Lcb2p-like domain of the full-length protein did not
abolish all glycosylation (data not shown), glycosylation of the
full-length vSPT is apparently different from that of the sepa-
rated domains. Analysis of the coexpressed vSPT subunits also
showed that stable expression of the vSPT Lcb2p-like protein
does not depend upon the presence of the vSPT Lcb1p-like
protein (Fig. 6, A and B). This is in sharp contrast to the situa-
tion in both yeast and mammals where the stability of mono-
FIGURE 4. vSPT does not rescue a hem1 mutant and is inhibited by
myriocin. A, wild type (HEM1) or hem1 yeast were transformed with
pADH1 or a vSPT-expressing pADH1 plasmid, and the transformants were
tested for growth on YPD plates with (ALA) or without (ALA) aminole-
vulinic acid. B, SPT activity was assayed using microsomes prepared from
wild type (yeast SPT) or lcb1 cells expressing vSPT (vSPT) in the presence
of the indicated concentrations of myriocin.
FIGURE 5. vSPT is a single-chain ER-associated protein. A, 10 g of micro-
somal protein from cells expressing 3HA-vSPTwere resolved by SDS-PAGE
before or after treatment with endoglycosidase H (EndoH). vSPT was visual-
ized by immunoblotting as described under “Experimental Procedures.” Loss
of the highermolecular weight form after endoglycosidase H treatment indi-
cates N-glycosylation. B, the intracellular localization of GFP-vSPT and GFP-
Lcb1p was determined by fluorescence microscopy.
FIGURE6. Independentlyexpresseddomainsof thevSPT reassemble into
an active protein. A and B, microsomes prepared from cells expressing full-
lengthHA-vSPT (lanes 1 and 2), the HA-taggedN-terminal domain (HA-vLCB2)
of the vSPT (lanes 3 and 4), theMyc-taggedC-terminal domain (Myc-vLCB1) of
vSPT (lanes 5 and 6), or both the N- and C-terminal domains (lanes 7 and 8)
were resolved by SDS-PAGE after treatmentwith orwithout endoglycosidase
H (EndoH). The tagged proteins were detected with anti-HA (A) or anti-Myc
(B). The approximate 54-kDa protein seen in all lanes (B) is an anti-Myc cross-
reactive protein unrelated to vSPT. C, Lcb1 mutant cells expressing full-
length vSPT, vLCB2, vLCB1, or both vLCB2 and vLCB1 were tested for growth
with (left) or without (right) PHS at 26 °C. D, SPT activity was assayed using
microsomes prepared from lcb1mutant cells expressing full-length vSPT or
vLCB2 and vLCB1 using myristoyl-CoA (C14) or palmitoyl-CoA (C16) as the
acyl-CoA substrates.
Single-chain Serine Palmitoyltransferases
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meric Lcb2p is strictly dependent upon the presence of Lcb1p
(3, 11, 12).
Characterization of a Yeast Single-chain SPT Provides
Additional Evidence for Structural Plasticity of the SPT En-
zymes—The discovery of this novel viral fusion SPT enzyme
composed of two separable domains suggested that fusion of
the two subunits of the yeast and other eukaryotic SPTs
would yield active enzymes. To test this possibility, full-length
yeast Lcb1p was fused to the C terminus of Lcb2p to create a
yeast Lcb2-Lcb1p fusion protein. Expression of this fusion pro-
tein provided sufficient SPT activity to complement the LCB-
requiring phenotype of a yeast lcb1 lcb2 mutant (Fig. 7B).
Unlike the vSPT, the yeast fusion protein was dependent on
Tsc3p for full activity, demonstrating that like the native het-
erodimer the yeast fusion protein retains its interaction with
Tsc3p. SPT activity assays showed that the yeast Lcb2-Lcb1p
fusion protein, which was expressed to the same extent as the
individual subunits (Fig. 7A), had30% as much activity as the
native Lcb2p/Lcb1p heterodimer when assayed with C16-CoA
as the substrate (Fig. 7C). However, with C14-CoA as the sub-
strate the activity of the fusion protein was 60% that of the
native enzyme, and with C12-CoA as substrate, the fusion pro-
tein and the native protein had equivalent activities. Thus, it
appears that like vSPT, the yeast fusion protein has an altered
substrate preference. In addition, a human hSPTLC2-SPTLC1
fusion protein was active when expressed in a Chinese hamster
ovary cell line lacking endogenous SPT activity (Fig. 7,D andE),
demonstrating that the ability to construct an active SPT chi-
mera is a general property of this protein.
The data presented thus far are consistent with the conclu-
sion that the fusion proteins fold as monomers with single
active sites formed at the interface between the two domains.
However, the possibility that two full-length fusion proteins
associate to form a head-to-tail homodimer, creating an
enzyme with two active sites, cannot be excluded. Two lines of
evidence argue that this is not the case. First, coexpression of a
yeast Lcb2-Lcb1p fusion protein containing an inactivating
mutation at the lysine residue of the Lcb2p domain with a yeast
Lcb2-Lcb1p fusion protein containing an inactivatingmutation
at the cysteine residue of the Lcb1p domain did not rescue an
lcb1lcb2 mutant (data not shown). If the active form of the
enzyme were a head-to-tail homodimer, then coexpression of
these mutants should have yielded a population of dimers, 50%
of which contained one active site and one mutated site.
Because of the robust activity of the yeast Lcb2-Lcb1p fusion
protein (40 pmol/mg/min), even this reduced level of activity
should have been sufficient to restore growth. Second, if the
FIGURE 7.Yeast andhuman fusion SPTs are enzymatically active.A, 10g
of microsomal protein fromwild type yeast cells or cells expressing the yeast
Lcb2-Lcb1p fusion but lacking endogenous Lcb1p, lacking endogenous
Lcb2p, or lacking both Lcb1p and Lcb2pwere fractionated by SDS-PAGE, and
the subunits were visualized by immunoblotting using anti-Lcb1p (left) or
anti-Lcb2p (right). B, yeast lcb1lcb2 (rows 1 and 2) or lcb1lcb2tsc3 (row
3) mutant cells containing empty vector (row 1) or vector expressing yeast
Lcb2-Lcb1p (rows 2 and 3) were assayed for growth at 26 or 37 °C in the
presence or absence of PHS. C, SPT activities in microsomes prepared from
the wild type (WT) and the Lcb2-Lcb1p-rescued lcb1lcb2mutant (Fusion)
were assayed using acyl-CoA substrates of the indicated chain length.D, Ly-B
Chinese hamster ovary cells (24) were transfected with vector (lane 1),
hSPTLC1 (lane 2), or hSPTLC1-SPTLC2 (lane 3), and the expressed protein was
detected by immunoblotting using anti-hSPTLC1. E, microsomes prepared
from transfected cells were assayed for SPT activity as in C.
Single-chain Serine Palmitoyltransferases
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Lcb1p domain of the yeast Lcb2-Lcb1p fusion proteinwere able
to associate with the Lcb2p domain of a second fusion protein,
then it should also be able to associate with, and thereby stabi-
lize an Lcb2p monomer. However, the immunoblot clearly
shows that there is no Lcb2p monomer stabilized in the lcb1
mutant expressing the fusion protein (Fig. 7A). Thus, we con-
clude that the active form of SPT fusion proteins is a folded
monomer.
DISCUSSION
Sequencing of the Coccolithovirus genome identified a puta-
tive SPT-encoding gene in which both subunits of the classical
enzyme are contained in a single ORF (6). Similar fusion pro-
teins are found in EST libraries from E. huxleyi,3 and Acan-
thamoeba histolytica (18). For all three single-chain proteins,
the N-terminal domain most closely resembles the Lcb2p sub-
unit of traditional SPTs, and the C-terminal domain most
closely resembles the Lcb1p subunit. However, in the absence
of genomic sequence from either organism it is unclear that
these are the only SPTs present or how the genes that encode
them are organized. In addition, since the domains of vSPT are
nomore homologous to those of the putative SPT from the host
than they are to the individual subunits of yeast,Arabidopsis, or
mammalian SPTs, the phylogenetic relationship between the
viral and host SPT fusion proteins is not apparent.
The unique preference of vSPT for C14-CoA suggests that
during infection it might function as a serine myristoyltrans-
ferase. However, because little is known about the sphingolipid
composition of E. huxleyi, it is also possible that theremay be as
yet unidentified substrates that are condensed with serine.
Although when measured 24 h after infection, the ratio of C16:
C18 LCBs was greater in infected cells than has been seen in
other organisms, this increased ratio was also observed in unin-
fected cells. Thus, despite the relatively low homology between
the viral and host enzymes, there is no evidence that this trans-
lates into an altered profile of LCBs. Resolution of the question
of whether expression of vSPT and other virally encoded sphin-
golipid genes alter LCB or complex sphingolipid composition
will require more extensive sphingolipid profiling over the
entire course of EhV-86 infection.
When proteins are found as multidomain “chimera,” it has
been suggested that elsewhere in nature there will be examples
where the individual domains are contained in separate pro-
teins that heterodimerize (19). Thus, the presence of naturally
occurring single-chain and heterodimeric SPTs is not entirely
surprising. Structural plasticity in the -oxoamine synthases
was also suggested by studies on murine erythroid 5-aminole-
vulinate synthase, a homodimeric-oxamine synthasewith sig-
nificant homology to SPT, which is active in at least three cir-
cularly permutated configurations (20–22). In addition, we
have previously shown that the Lcb1p subunit of yeast and
mammalian SPT can tolerate insertion of a 53-amino acid
domain from yeast invertase at multiple positions without loss
of activity (12). These results led us to consider the possibility
that yeast and/or mammalian SPT, expressed as a single-chain
fusion, would be active. Our results clearly demonstrate that
this is the case. In addition, the yeast fusion protein localizes
to the same intracellular organelle, and its maximum activity
depends on the presence of Tsc3p, indicating that the single-
chain protein retains many important properties of the
native heterodimer. A yeast Lcb1-Lcb2p chimera also
showed some activity (data not shown). Thus, an active
enzyme can be formed in at least three different ways, dem-
onstrating a high degree of flexibility in the formation of its
active site. It should be pointed that although the vSPT is not
proteolytically cleaved to distinct domains in yeast, we can-
not exclude the possibility that this or other posttransla-
tional modifications that could alter substrate specificity
occur in the algal host. In addition, although there is noTsc3p-
like protein encoded within the viral genome, it is possible that
the viral genome encodes a functional ortholog or that the host
expresses such a protein.
One property of the single-chain yeast protein significantly
different from that of the native heterodimer was its relative
preference for shorter chain acyl-CoA substrates. Unlike the
native heterodimer, maximum activity was obtained with C14-
CoA, and the enzyme was just as active with C12-CoA as with
C16-CoA. Although the altered substrate preference of the sin-
gle-chain yeast SPT is comparable with the preference of the
viral enzyme, it is not clear towhat extent this reflects an intrin-
sic property of single-chain SPTs since when the viral protein
was expressed as individual domains it retained its preference
for C14-CoAs. Nonetheless, altered preference and high activ-
ity of the yeast single-chain protein offers a novel approach for
altering the cellular levels of the shorter LCBs and their meta-
bolic products, including LCB-Ps and ceramides, which have
been implicated in numerous signaling pathways.
It is commonplace to study structure-function relationships
by rearranging protein domains or swapping domains fromone
protein to another. In addition, expression of the heterodimeric
gonadotropin hormones as single-chain chimera has allowed
the folding of these hormones to be investigated in great detail
(23). The data presented here demonstrate that the same
approach can be applied to the study of multisubunit mem-
brane-associated proteins. Characterization and purification of
such proteins has proven difficult in part because of subunit
dissociation during solubilization. If, as is the case with SPT,
expression of individual subunits as a single-chain chimera
does not substantively alter the essential properties of the
enzyme, preservation of quaternary structure should be less
difficult. Finally, our results demonstrate that, as has been
shown to be the case for mammalian and plant genes, expres-
sion and characterization of novel sphingolipid genes from
marine organisms in appropriate yeast mutants can provide
important insights into the role of these genes in their native
hosts.
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